Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.

MLA

Crawford DK, et al. “Oestrogen Receptor Beta Ligand: A Novel Treatment to Enhance Endogenous Functional Remyelination.” Brain: A Journal of Neurology, vol. 133, no. 10, Oct. 2010, pp. 2999–3016. EBSCOhost, https://doi.org/10.1093/brain/awq237.

APA

Crawford DK, Mangiardi M, Song B, Patel R, Du S, Sofroniew MV, Voskuhl RR, Tiwari-Woodruff SK, Crawford, D. K., Mangiardi, M., Song, B., Patel, R., Du, S., Sofroniew, M. V., Voskuhl, R. R., & Tiwari-Woodruff, S. K. (2010). Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Brain: A Journal of Neurology, 133(10), 2999–3016. https://doi.org/10.1093/brain/awq237

Chicago

Crawford DK, Mangiardi M, Song B, Patel R, Du S, Sofroniew MV, Voskuhl RR, et al. 2010. “Oestrogen Receptor Beta Ligand: A Novel Treatment to Enhance Endogenous Functional Remyelination.” Brain: A Journal of Neurology 133 (10): 2999–3016. doi:10.1093/brain/awq237.